Systemic review of epidemiology, pathogenesis, clinical manifestations, classification, and 2019 updated recommendation of managements for systemic lupus erythematosus

Ya Chun Huang, Meng Yu Weng

研究成果: Review article同行評審

摘要

Systemic lupus erythematosus (SLE) is an autoimmune disease that mostly affects women in reproductive age. The complexity of the signs and symptoms of SLE may attribute to the activation of complement system and subsequent immunocomplex deposition in a susceptible subject. Therefore, associated differential diagnosis with other diseases is essential. The clinical classification of SLE remains the challenge for rheumatologists. In 2019, EULAR and ACR published the updated recommendations for management of SLE; the recommendations for the managements of lupus nephritis and antiphospholipid syndrome (APS) were also published last year. In this article, we aim to provide a comprehensive review of epidemiology, pathogenesis, clinical manifestations, classification, and updated recommendations published in 2019 of SLE.

原文English
頁(從 - 到)108-120
頁數13
期刊Journal of Internal Medicine of Taiwan
32
發行號2
DOIs
出版狀態Published - 2021 4月

All Science Journal Classification (ASJC) codes

  • 內科學

指紋

深入研究「Systemic review of epidemiology, pathogenesis, clinical manifestations, classification, and 2019 updated recommendation of managements for systemic lupus erythematosus」主題。共同形成了獨特的指紋。

引用此